Although mucosal vaccination with LAIV generates virus-specific cytotoxic CD8+ T lymphocytes (CTL), the systemic hemagglutinin (HA)-specific neutralizing antibodies generated are generally less robust compared to inactivated influenza vaccines (IIVs) [1,2,3]. Here, CD8A is linked to influenza.